LUMA BIO-IT MANAGEMENT, LLC
LUMA BIO-IT MANAGEMENT, LLC is a Pre-seed, Seed, Series A, Series B, Series C+, early-stage and mid-stage fund in global writing $5M–$20M checks into biotechnology, therapeutics, diagnostics, medical-devices, precision-medicine, regenerative-medicine, rna-based-therapeutics, small-molecules, vaccines, cardiology, dermatology, endocrinology, gastroenterology, hematology, immunology, metabolism, neurology, oncology, ophthalmology, pulmonology, rare-diseases, biologics and protein-based-therapies.
- Stages
- Pre-seed, Seed, Series A, Series B, Series C+, early-stage, mid-stage
- Sectors
- biotechnology, therapeutics, diagnostics, medical-devices, precision-medicine, regenerative-medicine, rna-based-therapeutics, small-molecules, vaccines, cardiology, dermatology, endocrinology, gastroenterology, hematology, immunology, metabolism, neurology, oncology, ophthalmology, pulmonology, rare-diseases, biologics, protein-based-therapies
- Check size
- $5M–$20M
- Invests in
- global
- Actively investing
- Yes
- Founded
- 2018
- Website
- lumagroup.com
Thesis
LUMA BIO-IT MANAGEMENT, LLC is a venture capital firm founded in 2018 that invests in the biotechnology sector, with a focus on companies developing innovative solutions in precision medicine, diagnostics, and next-generation therapeutics. Their investment strategy targets early and mid-stage companies (pre-seed through Series B) that are developing first-in-class or best-in-class assets. The firm's areas of interest include a wide range of modalities such as biologics, protein-based therapies, regenerative medicine, RNA-based therapeutics, small molecules, and vaccines, across numerous therapeutic areas including oncology, neurology, and rare diseases. LUMA BIO-IT MANAGEMENT, LLC typically leads or co-leads financings with initial checks ranging from $5 million to $20 million. They offer not only capital but also strategic, operational, and scientific support, utilizing an AI-driven analysis system called LABI to accelerate data analysis and identify potential. The firm operates globally and is headquartered in New York, NY.
Common questions
Does LUMA BIO-IT MANAGEMENT, LLC invest at the Pre-seed stage?
Yes. LUMA BIO-IT MANAGEMENT, LLC lists Pre-seed, Seed, Series A, Series B, Series C+, early-stage and mid-stage among the stages it invests in.
What check size does LUMA BIO-IT MANAGEMENT, LLC write?
LUMA BIO-IT MANAGEMENT, LLC writes $5M–$20M checks.
Where does LUMA BIO-IT MANAGEMENT, LLC invest?
LUMA BIO-IT MANAGEMENT, LLC invests in global.